At CURA Diagnostics, our mission is to establish ourselves as a premier diagnostic company dedicated to providing comprehensive solutions that cater to the evolving diagnostic needs within the realms of Drug-of-Abuse (DOA) and Therapeutic Drug Monitoring (TDM). Our commitment extends from sample collection, initial screening to confirmatory testing, with a focus on accuracy, efficiency, and innovation

Served on the board of directors for various portfolio companies including: Avida Biomed, Wellcome MD, Worg Pharmaceutical, Alanber clinics etc

- Junson Capital is a single family office with global operations across various sectors including real estate, healthcare etc.- Project leads identification, tracking, evaluation, and due diligence work;- Lead deal structure design, financial analysis, investigation, valuation and return analysis, etc.- Lead deal negotiation, formulate investment proposal, and complete investment execution;- Support portfolio companies post investment: fund raising, executive team building, corporate strategy- Design company's investment strategy in healthcare sector- Support needs of healthcare research from Global Public Market department.- Selected principle investments: Apexigen (APGN), Avida Biomed (Seed investor, Acquired by Agilent) WellcomeMD, Worg Pharmaceuticals, Apollomics (APLM), I-MAB (IMAB), Sillicon Therapeutics (Acquired by Roivant) etc

Member of Founding Team: - Fund raising activities: identifying investors, organizing road-show, termsheet negotiation etc- Established a CAP accredited clinical laboratory that offers more than 130 tests utilizing various methodologies including automated clinical chemistry, ELISA, electrophoresis, mass spectrometry, molecular diagnostics, microbiology etc: acquisition and selection of instrumentation, vendor selection, assay development and validation, development of daily process for routine clinical sample analysis.- Designed and executed the development plan for lab capacity in accordance with sales growth. Grew laboratory capacity from establishment to 200 daily accessions.- Established quality improvement, fiscal productivity, and client satisfaction goals.- Developed staffing plans, provided coaching, guidance, and on-the-job training and retraining, as necessary, to ensure operational efficiency and adherence to policies and procedures.- Oversee lab operation and new assay validation and development.- Review and negotiate purchase agreement/contract with vendors.- Monitor resource utilization, including payroll, supplies, expenses, and prepare monthly lab cost analysis reports for the financial department.

- Oversee all technical matters on routine laboratory testing in Special Chemistry division with focuses on high through-put ELISA, electrophoresis and multiplex assays which had challenge to automate. - Design, lead and manage the improvements in quality and efficiency in a fast pace and high through-put clinical laboratory: - Grew laboratory capacity from 2000 daily accessions to 4000. - Reduced assay failure rate by more than 60%. - Supervise and manage lab staff.- Laboratory accreditation experience: work closely with QA department throughout CAP and CLIA onsite inspection process.

- Primarily responsible for day-to-day management of all technical matters on routine laboratory testing from sample receipt through analysis- Assisted center director to supervise laboratory specialists, evaluate workload and establish priorities.- Provided technical training to scientists within or outside of the company- Kept and ensured accurate documentation of laboratory work in compliance with CLIA regulation- Established, evaluated and validated various laboratory SOPs for detecting antibodies in human sera or viral DNA in tissue specimen including the first adenovirus type specific double-antigen ELISA (US patent pending) and the first human adenovirus 36 type specific qPCR assay.- Generated method development reports and other documents for investors and patent application in a timely manner.- Prepared manuscripts for scientific journals and presented work at various national and international conferences.

Research emphasis: determining the metal binding properties and regulation of two major metal transport proteins (FeoB1 and FeoB2) in oral pathogen using a series of biochemical and microbiological approaches. This required extensive knowledge of conventional microbiology techniques and molecular biology skills, including: - Aerobic and anaerobic gram-negative bacteria including Escherichia coli, Porphyromonas gingivalis culture techniques with both liquid and solid media- Phase contrast and confocal laser microscopy- Gene expression analysis by microarray and real-time RT PCR.- Development of growth study, in-vitro bacterial invasion and intracellular survival modeling protocol